Morgan Stanley Starts Senti Biosciences, Inc. (SNTI) at Equalweight

October 7, 2022 3:58 AM EDT Send to a Friend
Morgan Stanley analyst Michael Ulz initiates coverage on Senti Biosciences, Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login